케메드(CHE) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
| Index | - | P/E | 27.76 | EPS (ttm) | 18.35 | Insider Own | 1.85% | Shs Outstand | 13.2M | Perf Week | -0.84% |
| Market Cap | 6.76B | Forward P/E | 18.95 | EPS next Y | 10.43% | Insider Trans | -2.93% | Shs Float | 13.0M | Perf Month | 12.4% |
| Enterprise Value | 6.99B | PEG | 1.86 | EPS next Q | 5.6 | Inst Own | 103.3% | Short Float | 4.34% | Perf Quarter | 20.95% |
| Income | 0.26B | P/S | 2.66 | EPS this Y | 12.96% | Inst Trans | -3.89% | Short Ratio | 2.67 | Perf Half Y | 14% |
| Sales | 2.54B | P/B | 7.94 | EPS next 5Y | 10.21% | ROA | 15.93% | Short Interest | 0.57M | Perf YTD | 19.04% |
| Book/sh | 64.15 | P/C | 401.01 | EPS past 3/5Y | 3.52% -1.2% | ROE | 25.6% | 52W High | -1.62% ($517.74) | Perf Year | 8.2% |
| Cash/sh | 1.27 | P/FCF | 17.93 | Sales past 3/5Y | 5.82% 4% | ROIC | 24.89% | 52W Low | 39.47% ($365.20) | Perf 3Y | -2.19% |
| Dividend Est. | $2.46 (0.48%) | EV/EBITDA | 17.74 | EPS Y/Y TTM | -11.26% | Gross Margin | 29.68% | Volatility(W/M) | 2.52% 2.42% | Perf 5Y | 6.07% |
| Dividend TTM | 2.4 | EV/Sales | 2.75 | Sales Y/Y TTM | 2.07% | Oper. Margin | 12.93% | ATR (14) | 12.15 | Perf 10Y | 241.88% |
| Dividend Ex-Date | 2026/5/28 | Quick Ratio | 0.83 | EPS Q/Q | -0.35% | Profit Margin | 10.23% | RSI (14) | 69.25 | Recom | 2.6 |
| Dividend Gr. 3/5Y | 14.13% 10.76% | Current Ratio | 0.85 | Sales Q/Q | 1.63% | SMA20 | 3.38% ($492.69) | Beta | 0.5 | Target Price | $474 |
| Payout | 11.99% | Debt/Eq | 0.29 | Earnings | 2026/7/28 | SMA50 | 11.03% ($458.74) | Rel Volume | 0.77 | Prev Close | $511.13 |
| Employees | 15811 | LT Debt/Eq | 0.23 | EPS/Sales Surpr. | 6.55% 1.18% | SMA200 | 17.38% ($433.92) | Avg Volume(3M) | 0.21M | Price | $509.34 |
| IPO | 1982/6/29 | Option/Short | Yes/Yes | Trades | 4880 | Volume | 163,745 | Change | -0.35% |
Chemed Corp (CHE) Investment Analysis
What kind of company is Chemed Corp?
A US-based company that operates two businesses side by side: hospice (end-of-life care) medical services and plumbing/sewer repair services. It owns two distinctly different businesses — one of the largest hospice operations in the US and a plumbing repair franchise — making it a diversified name whose performance is tied to both aging-driven hospice demand and plumbing service demand. It is also known for paying dividends.
Learn more about Chemed Corp →Key Events
Is it profitable?
What's the outlook?
Did earnings meet expectations?
Is it growing?
Has the stock risen over the long term?
Technical Indicators
Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 137-day series
Price · Bollinger Bands · Ichimoku Cloud
- close
- BB Upper
- BB Mid
- BB Lower
- Tenkan
- Kijun
- Cloud (SpanA/B)
Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →
Current price $509.34 above the midline ($492.70). Normal upward flow. Above the Ichimoku cloud (bullish).
MACD (12 · 26 · 9) Expand ▼
An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →
MACD(15.758) crossed below Signal(16.019). Trend reversal possible; read as a sell entry point.
RSI(14) · Stochastics %K(14) Expand ▼
RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →
RSI 69.3 (above the neutral level of 50). Buying pressure leads, supporting a steady rise. Stoch %K is also 81.5.
※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.
Is it attractive at this price?
Who owns it?
ETFs holding CHE
How much does it pay in dividends?
Compare Industry Peers
| Stock | Market Cap | PER | PBR | ROE | Dividend Yield | Change |
|---|---|---|---|---|---|---|
| $6.8B | 27.8 ▼ | 7.9 ▼ | 25.6% ▲ | 0.48% ▼ | -0.3% | |
LLY | $1.13T | 43.1 ▼ | 36.2 ▼ | 107.64% ▲ | 0.58% ▼ | +0.1% |
JNJ | $640.9B | 30.8 ▼ | 7.5 ▼ | 25.74% ▲ | 2.02% ▲ | +1.0% |
ABBV | $453.9B | 126.7 ▼ | - | 15221.82% ▲ | 2.67% ▲ | -0.9% |
UNH | $379.3B | 26.9 ▼ | 3.9 ▼ | 12.49% ▲ | 2.16% ▲ | -0.7% |
MRK | $323.0B | 36.8 ▼ | 7.0 ▼ | 18.97% ▲ | 2.5% ▲ | -0.2% |
| Sector Avg | - | 26.1 | 2.7 | -48.83% | 1.23% | - |
FAQ
What kind of company is 케메드(CHE)?
케메드(CHE) belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of CHE?
The market cap of CHE is approximately $6.8B, ranking 1,186 within its sector.
Does CHE pay dividends?
CHE has a dividend yield of approximately 0.48%, with an annual dividend of $2.46.
What is the P/E ratio of CHE?
CHE has a P/E ratio of approximately 27.8x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for CHE?
CHE has recorded a 52-week high of $517.74 and a low of $365.20.
면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.